Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells

Adrian Manea1, Laurentia Irina Tanase, Monica Raicu

  • 1Institute of Cellular Biology and Pathology "Nicolae Simionescu," 8, BP Hasdeu St, Bucharest, PO Box 35-14, Romania.

Abstract

Insights

The JAK/STAT pathway regulates Nox1 and Nox4 in human aortic smooth muscle cells, impacting vascular disease. Inhibiting this pathway reduces oxidative stress, offering a potential therapeutic strategy for atherosclerosis.

Area of Science:

  • Vascular Biology
  • Molecular Medicine
  • Cell Signaling

Background:

  • Oxidative stress, driven by NADPH oxidase (Nox) enzymes like Nox1 and Nox4, is crucial in vascular diseases.
  • The precise molecular mechanisms regulating Nox enzymes remain incompletely understood.
  • The JAK/STAT pathway influences genes involved in inflammation, proliferation, and differentiation, prompting investigation into its role in Nox regulation.

Purpose of the Study:

  • To investigate the involvement of the JAK/STAT signaling pathway in the regulation of Nox1 and Nox4 in human aortic smooth muscle cells (SMCs).

Main Methods:

  • Human aortic SMCs were treated with interferon gamma (IFNγ).
  • Nox activity and expression were assessed using chemiluminescence assays, real-time PCR, and Western blotting.
  • In silico analysis, promoter activity assays, and chromatin immunoprecipitation identified STAT1/STAT3 binding sites and interactions within Nox gene promoters.

Main Results:

  • JAK/STAT inhibitors significantly reduced IFNγ-induced upregulation of Nox activity, Nox1, and Nox4 expression.
  • STAT1/STAT3 proteins physically interacted with conserved GAS elements in the Nox1 and Nox4 promoters.
  • JAK/STAT pathway blockade decreased the transcription of Nox subunits.

Conclusions:

  • The JAK/STAT pathway is a critical regulator of Nox1 and Nox4 in human vascular SMCs.
  • Targeting the JAK/STAT pathway and subsequent Nox-dependent oxidative stress presents a promising therapeutic approach for reducing atherogenesis.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Paracrine Signaling01:21

Paracrine Signaling

Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...